Search
Powered By HealthLine
Health Tools
 Pain Management
 Pain Management Drug Info
 Chronic Pain Q&A
 Chronic Pain Forum
 Fibromyalgia Quiz
Featured Conditions
 Chronic Pain
 Osteoarthritis
 Rheumatoid Arthritis
 Osteoporosis
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & Precautions
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Dilantin

[Phenytoin]


Side Effects & Drug Interactions
ADVERSE REACTIONS

Central Nervous System


Text Continues Below



Drug Interactions:

There are many drugs which may increase or decrease phenytoin levels or which phenytoin may affect. Serum level determinations for phenytoin are especially helpful when possible drug interactions are suspected. The most commonly occurring drug interactions are:

1. Drugs which may increase phenytoin serum levels include:

acute alcohol intake,
amiodarone,
chloramphenicol,
chlordiazepoxide,
diazepam,
dicumarol,
disulfiram,
estrogens,
ethosuximide,
fluoxetine,
H2-antagonists,
halothane,
isoniazid,
methylphenidate,
phenothiazines,
phenylbutazone,
salicylates,
succinimides,
sulfonamides,
tolbutamide,
trazodone.

2. Drugs which may decrease phenytoin levels include:

carbamazepine,
chronic alcohol abuse,
reserpine,
sucralfate.

Moban® brand of molindone hydrochloride contains calcium ions which interfere with the absorption of phenytoin. Ingestion times of phenytoin and antacid preparations containing calcium should be staggered in patients with low serum phenytoin levels to prevent absorption problems.

3. Drugs which may either increase or decrease phenytoin serum levels include:

phenobarbital,
sodium valproate,
valproic acid.

Similarly, the effect of phenytoin on phenobarbital, valproic acid, and sodium valproate serum levels is unpredictable.

4. Although not a true drug interaction, tricyclic antidepressants may precipitate seizures in susceptible patients and phenytoin dosage may need to be adjusted.

5. Drugs whose efficacy is impaired by phenytoin include:

corticosteroids,
coumarin anticoagulants,
digitoxin,
doxycycline,
estrogens,
furosemide,
oral contraceptives,
quinidine,
rifampin,
theophylline,
vitamin D.

Drug/ Laboratory Test Interactions:

Phenytoin may cause decreased serum levels of protein-bound iodine (PBI). It may also produce lower than normal values for dexamethasone or metyrapone tests. Phenytoin may cause increased serum levels of glucose, alkaline phosphatase, and gamma glutamyl transpeptidase (GGT).

Carcinogenesis:

See WARNINGS section for information on carcinogenesis.
Pregnancy:

See WARNINGS section.

Nursing Mothers:

Infant breast feeding is not recommended for women taking this drug because phenytoin appears to be secreted in low concentrations in human milk.

Pediatric Use:

See DOSAGE AND ADMINISTRATION section.









HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire